Nonprofit Association of Mother–Infant Cytomegalovirus Infection | Italy
Author Profile
Scopus
Orcid
👨🎓 Early Academic Pursuits
Prof. Giovanni Nigro began his medical journey with an enduring passion for pediatrics and infectious diseases. Specializing in Pediatrics, Gastroenterology, and Infectious Diseases, he built a multidisciplinary foundation that enabled him to bridge clinical care with research excellence. His academic expertise quickly led him to become a leading figure in pediatric medicine at the University of L’Aquila, Italy, where he served as Director of the Pediatric Unit and School of Pediatrics.
🌍 Professional Endeavors
Prof. Nigro has an international footprint in medical education and research. His visiting professorships at elite institutions—such as St. George’s Hospital Medical School (London), the Swedish Institute for Infectious Disease Control (Stockholm), the Central Public Health Laboratory (London), and the Medical College of Virginia—reflect his global influence and leadership in pediatric infectious diseases. Through lectures and collaborative research, he has mentored countless young professionals and enriched the global pediatric and virology communities.
🔬 Contributions and Research Focus
A prolific scholar, Prof. Nigro has authored or co-authored over 330 publications, with 74 appearing in high-impact peer-reviewed journals. His research focuses prominently on congenital cytomegalovirus (CMV) infection, maternal-fetal infections, and pediatric virology. He is internationally recognized for his groundbreaking work in hyperimmune globulin therapy, antiviral treatments, and CMV disease outcomes. His recent studies, including clinical trials on CMV prevention, have reshaped treatment protocols and improved neonatal health outcomes globally.
🏅 Accolades and Recognition
Prof. Nigro is a highly respected figure in the international medical community. He has served as a referee for prestigious journals such as The Lancet, Journal of Pediatrics, Clinical Infectious Diseases, and Gastroenterology. His contributions are frequently cited in leading textbooks like Harrison’s Internal Medicine, Nelson Textbook of Pediatrics, and Remington & Klein’s Infectious Diseases of the Fetus and Newborn Infant, cementing his role as a pioneer in his domain.
💡 Impact and Influence
Prof. Nigro’s influence transcends academia. His clinical insights and translational research have significantly impacted public health policies and therapeutic guidelines for managing congenital CMV. He has been a key collaborator with renowned experts worldwide, from Sweden and the UK to the US and Germany, facilitating international research initiatives that continue to yield global health benefits.
🌟 Legacy and Future Contributions
Prof. Nigro’s legacy lies in his enduring contributions to pediatric infectious disease management and his role as a mentor and thought leader. With recent impactful publications in Viruses, NEJM, and Clinical Infectious Diseases, he continues to drive forward innovations in antiviral therapies and fetal medicine. His work remains crucial in addressing maternal-fetal health challenges, ensuring a healthier start to life for future generations.
Publications
📄 Foscarnet versus ganciclovir for severe congenital cytomegalovirus infection: Short- and long-term follow-up
Authors: Nigro G, Buzzi M, Catenaro M, Coclite E, Muselli M
Journal: Viruses
Year: 2025
📄 Prevention of congenital cytomegalovirus infection: Review and case series of valaciclovir versus hyperimmune globulin therapy
Authors: Nigro G, Muselli M
Journal: Viruses
Year: 2023
📄 Hyperimmune globulin for congenital cytomegalovirus infection
Author: Nigro G
Journal: The New England Journal of Medicine
Year: 2022
📄Serial Monitoring and Hyperimmunoglobulin versus Standard of Care to Prevent Congenital Cytomegalovirus Infection: A Phase III Randomized Trial
Authors: Devlieger R, Buxmann H, Nigro G, et al.
Journal: Fetal Diagnosis and Therapy
Year: 2021
📄 High-dose cytomegalovirus (CMV) hyperimmune globulin and maternal CMV DNAemia independently predict infant outcome in pregnant women with a primary CMV infection
Authors: Nigro G, Adler SP; Congenital Cytomegalic Disease Collaborating Group
Journal: Clinical Infectious Diseases
Year: 2020